Wei‐Wen Su - Concepedia

Author

Wei‐Wen Su

Changhua Christian Hospital ORCID

Also Known As

Chia-Jui Yen, Chih‐Lin Lin, Hsu-Heng Yen, Jia-Horng Kao, W Su, W. Su, W.-W. Su, W.W. Su, Wei-Wen Su, Wei‐Wen Su

143

Publications

Citations

H-Index

Concepts

All Affiliations

Changhua Christian Hospital National Taiwan University Hospital China Medical University China Medical University Hospital Kaohsiung Medical University

About

Wei‐Wen Su is an author at Changhua Christian Hospital specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	1.4K
2	Epidemiology	6	6	103
3	Health Sciences	3	3	535
4	Cell Biology	1	1	16
5	Diabetes	1	1	68

Wei‐Wen Su

Publications

Citations

H-Index

Page 1

	Year	Citations
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, The Lancet Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma	2023	415
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients Tung‐Hung Su, Tsung‐Hui Hu, Chi‐Yi Chen, Liver International	2016	217
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses Chun‐Jen Liu, Wan‐Long Chuang, Chuan–Mo Lee, Gastroenterology Dual Chronic InfectionHepatologyHepatitis CViral HepatitisImmunology	2008	212
Disturbance of circadian gene expression in hepatocellular carcinoma Yueh‐Min Lin, Julia Huei‐Mei Chang, Kun‐Tu Yeh, Molecular Carcinogenesis	2008	165
Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in Taiwan Sheng‐Nan Lu, Wei‐Wen Su, Sheng‐Shun Yang, International Journal of Cancer	2006	134
Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients Chien‐Hung Chen, Ting‐Tsung Chang, Ken‐Sheng Cheng, Liver International	2006	86
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan Pei‐Chien Tsai, Hsing‐Tao Kuo, Chao‐Hung Hung, Journal of Hepatology OncologyHepatologyViral HepatitisLiver PhysiologyDiabetes	2022	68
Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma Jeng‐Wei Lu, Yueh‐Min Lin, Jan‐Gowth Chang, Medical Oncology HepatologyHuman Hepatocellular CarcinomaMedicineLiver PhysiologyHistopathology	2013	66
Long‐term trends and geographic variations in the survival of patients with hepatocellular carcinoma: Analysis of 11 312 patients in Taiwan Chien‐Hung Chen, Wei‐Wen Su, Sheng‐Shun Yang, Journal of Gastroenterology and Hepatology	2006	65

Page 1